Palantir reports Q4 earnings Monday with $1.34B revenue expected as Navy contracts and 121% commercial growth test premium ...
Molecular imaging is redefining in vivo characterization of multiple sclerosis, a demyelinating disease with complex and heterogeneous clinical profiles. Recent advances in PET tracers enable more ...